EUDA logo

EUDA Health Holdings Limited operates a digital health platform, offering virtual consultations for non-emergency medical (EUDA) Análisis de Acciones

Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

EUDA representa a EUDA Health Holdings Limited operates a digital health platform, offering virtual consultations for non-emergency medical, una empresa del sector Healthcare con un precio de $10.56 (capitalización de mercado 20M). Calificado con 46/100 (cauteloso) en potencial de crecimiento, salud financiera e impulso.

Ultimo analisis: 8 feb 2026
Puntuación de IA de 46/100 Objetivo $6.00 (-43.2%) MCap 20M Vol 4K

EUDA Health Holdings Limited operates a digital health platform, offering virtual consultations for non-emergency medical (EUDA) Resumen de Asistencia Médica y Tuberías

CEOAlfred Lim
Empleados117
Sede CentralSingapore, SG
Año de la oferta pública inicial (OPI)2021

EUDA Health Holdings pioneers accessible healthcare through its digital platform, offering virtual consultations for non-emergency medical issues. With a focus on the Southeast Asian market, EUDA leverages technology to bridge healthcare gaps and enhance patient convenience, positioning itself for growth in the evolving telehealth landscape.

Procedencia de los datos | Datos financieros Análisis cuantitativo NASDAQ Análisis: 8 feb 2026

Tesis de Inversión

EUDA Health presents a notable research candidate due to its strategic positioning in the rapidly growing telehealth market. With a market capitalization of $0.04 billion and a P/E ratio of 154.67, EUDA demonstrates potential for growth as it expands its digital health platform. The company's focus on virtual consultations for non-emergency medical issues addresses a critical need for accessible healthcare solutions, particularly in Southeast Asia. Key value drivers include increasing user adoption of telehealth services, strategic partnerships with healthcare providers, and expansion into new geographic markets. The company's 5.2% profit margin indicates operational efficiency, while its negative beta of -0.15 suggests lower volatility compared to the overall market. Upcoming catalysts include platform enhancements and expansion into new service offerings.

Basado en las finanzas de FMP y el análisis cuantitativo

Puntos clave

  • Market Cap of $0.04B indicates the company's current valuation in the market.
  • P/E Ratio of 154.67 suggests investors are willing to pay a premium for each dollar of earnings, reflecting growth expectations.
  • Profit Margin of 5.2% demonstrates the company's ability to generate profit from its revenue.
  • Gross Margin of 22.4% reflects the efficiency of EUDA's service delivery and cost management.
  • Beta of -0.15 indicates that the stock price is less volatile than the overall market, offering stability to investors.

Competidores y Pares

Fortalezas

  • Digital health platform providing convenient virtual consultations.
  • Focus on the growing Southeast Asian market.
  • Subsidiary of Watermark Developments Limited, providing financial backing.
  • Relatively low Beta indicates lower volatility.

Debilidades

  • Limited operating history since founded in 2019.
  • Small market capitalization of $0.04B.
  • High P/E ratio of 154.67 may indicate overvaluation.
  • Gross margin of 22.4% is relatively low.

Catalizadores

  • Upcoming: Platform enhancements to improve user experience and functionality.
  • Ongoing: Expansion into new geographic markets within Southeast Asia.
  • Ongoing: Strategic partnerships with healthcare providers to broaden service reach.

Riesgos

  • Potential: Competition from larger, more established telehealth providers.
  • Potential: Regulatory changes impacting the telehealth industry.
  • Potential: Cybersecurity breaches compromising patient data.
  • Ongoing: Dependence on Watermark Developments Limited for financial support.
  • Ongoing: Negative publicity impacting brand reputation.

Oportunidades de crecimiento

  • Expansion into New Geographic Markets: EUDA has the opportunity to expand its services into additional Southeast Asian countries, tapping into a larger pool of potential users. The Southeast Asian telehealth market is projected to experience significant growth, driven by increasing internet penetration and rising healthcare awareness. By establishing partnerships with local healthcare providers and adapting its platform to meet the specific needs of each market, EUDA can drive user adoption and revenue growth. Timeline: Within the next 2-3 years.
  • Enhancement of Service Offerings: EUDA can enhance its platform by incorporating additional services such as remote patient monitoring, chronic disease management, and mental health support. These value-added services can attract new users and increase engagement among existing users, driving revenue growth and strengthening EUDA's competitive position. The market for remote patient monitoring is expected to grow substantially as healthcare providers seek to improve patient outcomes and reduce costs. Timeline: Ongoing.
  • Strategic Partnerships with Healthcare Providers: EUDA can forge strategic partnerships with hospitals, clinics, and other healthcare providers to integrate its virtual consultation services into their existing workflows. These partnerships can provide EUDA with access to a broader patient base and enhance its credibility within the healthcare community. The healthcare industry is increasingly embracing digital health solutions, creating opportunities for collaboration and innovation. Timeline: Ongoing.
  • Leveraging AI and Data Analytics: EUDA can leverage artificial intelligence (AI) and data analytics to improve the efficiency and effectiveness of its virtual consultation services. AI-powered tools can assist with tasks such as appointment scheduling, preliminary diagnosis, and personalized treatment recommendations. By analyzing patient data, EUDA can identify trends and patterns to optimize its service offerings and improve patient outcomes. The market for AI in healthcare is rapidly growing, driven by the potential to improve efficiency and reduce costs. Timeline: Within the next 1-2 years.
  • Development of Mobile Health Applications: EUDA can develop mobile health applications to provide patients with convenient access to its virtual consultation services on their smartphones and tablets. Mobile health apps can enhance user engagement and improve patient adherence to treatment plans. The mobile health market is experiencing rapid growth, driven by the increasing adoption of smartphones and the growing demand for convenient healthcare solutions. Timeline: Within the next year.

Oportunidades

  • Expansion into new geographic markets within Southeast Asia.
  • Enhancement of service offerings to include remote patient monitoring.
  • Strategic partnerships with healthcare providers.
  • Leveraging AI and data analytics to improve service efficiency.

Amenazas

  • Competition from larger telehealth providers like Amwell.
  • Regulatory changes in the healthcare industry.
  • Cybersecurity risks associated with digital health platforms.
  • Economic downturns affecting healthcare spending.

Ventajas competitivas

  • Proprietary digital health platform that facilitates virtual consultations.
  • Established network of healthcare professionals and specialists.
  • Focus on the Southeast Asian market, providing a regional advantage.

Acerca de EUDA

EUDA Health Holdings Limited, established in 2019 and headquartered in Singapore, is a digital health company focused on providing virtual consultation services. Recognizing the increasing demand for accessible and convenient healthcare solutions, EUDA developed a platform that connects patients with healthcare professionals for non-emergency medical issues. As a subsidiary of Watermark Developments Limited, EUDA benefits from strategic support and resources to expand its reach and enhance its technological capabilities. The company's core offering revolves around its digital health platform, which enables patients to receive virtual consultations from qualified doctors and specialists. This service is particularly valuable for individuals seeking quick medical advice, prescription refills, or preliminary diagnoses without the need for in-person visits. EUDA's platform is designed to be user-friendly and accessible, catering to a diverse range of patients with varying levels of technological proficiency. EUDA's geographic focus is primarily on the Southeast Asian market, where there is a significant need for improved healthcare infrastructure and accessibility. By leveraging technology, EUDA aims to bridge the gaps in healthcare delivery and provide convenient, affordable solutions to patients in the region. The company's competitive positioning is centered on its ability to offer a seamless virtual consultation experience, leveraging its technology platform and network of healthcare professionals.

Qué hacen

  • Provides virtual consultations for non-emergency medical issues.
  • Connects patients with qualified doctors and specialists through a digital platform.
  • Offers convenient access to healthcare services without the need for in-person visits.
  • Facilitates prescription refills and preliminary diagnoses online.
  • Focuses on improving healthcare accessibility in Southeast Asia.
  • Operates as a subsidiary of Watermark Developments Limited.

Modelo de Negocio

  • Generates revenue through fees charged for virtual consultations.
  • Partners with healthcare providers to expand its service offerings.
  • Leverages technology to provide efficient and cost-effective healthcare solutions.

Contexto de la Industria

EUDA Health operates within the rapidly expanding telehealth market, driven by increasing demand for remote healthcare solutions and technological advancements. The global telehealth market is projected to reach billions of dollars in the coming years, fueled by factors such as aging populations, rising healthcare costs, and the need for convenient access to medical services. EUDA competes with other telehealth providers like AMWL (Amwell) and DTIL (DTI). EUDA's focus on Southeast Asia positions it to capitalize on the region's growing healthcare needs and increasing adoption of digital health technologies.

Clientes Clave

  • Individuals seeking quick medical advice for non-emergency issues.
  • Patients requiring prescription refills or preliminary diagnoses.
  • People in Southeast Asia with limited access to traditional healthcare services.
Confianza de la IA: 70% Actualizado: 8 feb 2026

Finanzas

Gráfico e información

Precio de la acción de EUDA Health Holdings Limited operates a digital health platform, offering virtual consultations for non-emergency medical (EUDA): $10.56 (-0.34, -3.09%)

Últimas noticias

Consenso de analistas

Calificación de Consenso

Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para EUDA.

Objetivos de Precios

Objetivo de consenso: $6.00

MoonshotScore

46/100

¿Qué significa esta puntuación?

El MoonshotScore califica el potencial de crecimiento de EUDA en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.

Lo Que los Inversores Preguntan Sobre EUDA Health Holdings Limited operates a digital health platform, offering virtual consultations for non-emergency medical (EUDA)

¿Cuáles son los factores clave para evaluar EUDA?

EUDA Health Holdings Limited operates a digital health platform, offering virtual consultations for non-emergency medical (EUDA) actualmente tiene una puntuación IA de 46/100, indicando puntuación baja. La acción cotiza a un P/E de 79.7x, por encima del promedio del S&P 500 (~20-25x), sugiriendo altas expectativas de crecimiento. Los analistas apuntan a $6.00 (-43% desde $10.56). Fortaleza clave: Digital health platform providing convenient virtual consultations.. Riesgo principal a monitorear: Potential: Competition from larger, more established telehealth providers.. Esto no es asesoramiento financiero.

¿Qué es el MoonshotScore de EUDA?

EUDA actualmente puntúa 46/100 (Grado D) en el MoonshotScore, lo que sugiere calificación baja. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.

¿Con qué frecuencia se actualizan los datos de EUDA?

Los precios de EUDA se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.

¿Qué dicen los analistas sobre EUDA?

Los analistas han establecido un precio objetivo de consenso de $6.00 para EUDA, representando un potencial bajista del 43% desde el precio actual de $10.56. La cobertura incluye calificaciones de compra, mantener y venta, estimaciones de ganancias y recientes mejoras o rebajas. Consulte la sección de Consenso de Analistas en esta página.

¿Cuáles son los riesgos de invertir en EUDA?

Las categorías de riesgo para EUDA incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Potential: Competition from larger, more established telehealth providers.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Con un P/E de 79.7x, la acción conlleva un riesgo de valoración elevado si las expectativas de crecimiento no se cumplen. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.

¿Cuál es la relación P/E de EUDA?

EUDA Health Holdings Limited operates a digital health platform, offering virtual consultations for non-emergency medical (EUDA) tiene una relación P/E de 79.7, que está por encima del promedio del mercado, lo que puede indicar altas expectativas de crecimiento. La relación P/E compara el precio de la acción con sus ganancias por acción. Compare con el promedio del S&P 500 (~20-25x) para contexto. Esto no es asesoramiento financiero.

¿Está EUDA sobrevalorada o infravalorada?

Determinar si EUDA Health Holdings Limited operates a digital health platform, offering virtual consultations for non-emergency medical (EUDA) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Su relación P/E es 79.7. Objetivo de analistas $6.00 (-43% desde el precio actual). Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.

¿Cuál es el rendimiento por dividendo de EUDA?

EUDA Health Holdings Limited operates a digital health platform, offering virtual consultations for non-emergency medical (EUDA) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.

Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.

Recursos Oficiales

Análisis actualizado el Puntuación de IA actualizada diariamente
Fuentes de Datos y Metodología
Datos de mercado proporcionados por Financial Modeling Prep y Yahoo Finance. Análisis de IA por algoritmos propietarios de Stock Expert AI. Indicadores técnicos mediante cálculos estándar de la industria. Última actualización: .

Datos proporcionados solo con fines informativos.

Notas de análisis
  • Information is based on limited available data.
  • Future performance is subject to market conditions and company-specific factors.
Fuentes de datos

Popular Stocks